The National Medical Commission has launched an investigation into doctors whose foreign trips, funded by AbbVie Healthcare, breached the U...

The company has achieved a key milestone for its novel MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor...

Alembic's product is therapeutically equivalent to AbbVie Inc's Biaxin Filmtab Tablets, which is antimicrobial indicated to treat mild to m...

In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squ...

The Apple stake reduction left Berkshire with a holding valued at about $120 billion at the end of 2020, according to another filing. The i...

So far in 2020, the S&P 500 pharmaceutical industry index has gained 0.6%, versus an 11.7% gain for the overall S&P 500, and an 8.8% gain f...

In a regulatory filing detailing its U.S.-listed stock holdings as of Sept. 30, Berkshire disclosed $5.7 billion of new healthcare stakes, ...

Pharma major Dr Reddy's Laboratories on Monday said it has launched generic lipid-regulating tablets in the US market.

The company has received approval from the United States Food and Drug Administration (USFDA) for its Divalproex Sodium extended-release ta...

The company's testosterone gel 1.62 per cent, which is a therapeutic equivalent generic version of AndroGel 1.62 per cent of AbbVie Inc, wa...

The tablets are indicated as replacement or supplemental therapy for hypothyroidism.

The approved product is therapeutically equivalent to the reference listed drug product Trilipix Delayed-Release capsules of Abbvie Inc.

The approval for trandolapril and verapamil hydrochloride extended release tablets has been granted to Glenmark Generics Inc.

According to IMS sales data, the product had a market size of around USD 690 million for the twelve months ended March 2014.

The company's US subsidiary, Lupin Pharmaceuticals Inc has launched the generic Niaspan tablets in multiple strengths of 500mg, 750 mg & 10...

Lupin said its US arm has launched generic Fenofibric Acid capsules used for reducing cholesterol and fatty acids in the blood in the Ameri...

US-based drug maker AbbVie Inc has dragged Dr Reddy's Lab to court for allegedly infringing the former's patented drug Zemplar on six count...